Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection
about
STAT3: A Novel Molecular Mediator of Resistance to ChemoradiotherapyMyD88 signaling in dendritic cells and the intestinal epithelium controls immunity against intestinal infection with C. rodentium.Beyond NK cells: the expanding universe of innate lymphoid cells.WASH maintains NKp46+ ILC3 cells by promoting AHR expression.Innate lymphoid cells facilitate NK cell development through a lymphotoxin-mediated stromal microenvironmentLacrimal gland-derived IL-22 regulates IL-17-mediated ocular mucosal inflammation.DOCK8 regulates protective immunity by controlling the function and survival of RORγt+ ILCsPD-1 regulates extrathymic regulatory T-cell differentiation.Restriction of IL-22-producing T cell responses and differential regulation of regulatory T cell compartments by zinc finger transcription factor IkarosRole of interleukin-22 in inflammatory bowel diseaseComplementarity and redundancy of IL-22-producing innate lymphoid cells.Transcriptional and epigenetic networks of helper T and innate lymphoid cells.STAT3-Activating Cytokines: A Therapeutic Opportunity for Inflammatory Bowel Disease?Innate Lymphoid Cells Control Early Colonization Resistance against Intestinal Pathogens through ID2-Dependent Regulation of the Microbiota.Cross-talk between type 3 innate lymphoid cells and the gut microbiota in inflammatory bowel disease.Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence.Nonredundant Roles of Interleukin-17A (IL-17A) and IL-22 in Murine Host Defense against Cutaneous and Hematogenous Infection Due to Methicillin-Resistant Staphylococcus aureus.Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammationAHR Function in Lymphocytes: Emerging ConceptsDOCK2 confers immunity and intestinal colonization resistance to Citrobacter rodentium infection.Ikaros Inhibits Group 3 Innate Lymphoid Cell Development and Function by Suppressing the Aryl Hydrocarbon Receptor Pathway.A single nucleotide polymorphism in the 3'-UTR of STAT3 regulates its expression and reduces risk of pancreatic cancer in a Chinese population.Innate immunity in the lung regulates the development of asthma.Development, differentiation, and diversity of innate lymphoid cells.IL-7Rα glutamylation and activation of transcription factor Sall3 promote group 3 ILC development.Immune deficiency vs. immune excess in inflammatory bowel diseases-STAT3 as a rheo-STAT of intestinal homeostasis.Innate lymphoid cells in intestinal immunity and inflammation.Heterogeneity and diversity of group 3 innate lymphoid cells: new cells on the block.Biological and pathological activities of interleukin-22.Immune modules shared by innate lymphoid cells and T cells.Functional and phenotypic heterogeneity of group 3 innate lymphoid cellsCD1d-mediated activation of group 3 innate lymphoid cells drives IL-22 production.Dynamic balance between master transcription factors determines the fates and functions of CD4 T cell and innate lymphoid cell subsets.Viral RNA-Unprimed Rig-I Restrains Stat3 Activation in the Modulation of Regulatory T Cell/Th17 Cell Balance.Type 3 innate lymphoid cell-derived lymphotoxin prevents microbiota-dependent inflammation.Long noncoding RNA lncKdm2b is required for ILC3 maintenance by initiation of Zfp292 expression.Prostaglandin E₂ constrains systemic inflammation through an innate lymphoid cell-IL-22 axis.Purification and Adoptive Transfer of Group 3 Gut Innate Lymphoid Cells.Probiotics inhibit immune fluctuation in the intestinal mucous layer in rats.Effects of selenium on myocardial apoptosis by modifying the activity of mitochondrial STAT3 and regulating potassium channel expression.
P2860
Q27003190-D4420600-37F5-4736-8AE6-3500B5FD71E0Q33693973-7912F2DE-A127-4023-93A6-927E91B85FC9Q33759935-320841F3-FEEF-41AD-9ABF-75ABC257A3D1Q33786520-9036D013-6116-42D8-AAE5-2A84F35D7A22Q33826833-3E16D899-0B37-4B86-AD67-18E4931B68F4Q33870377-CCE1B07D-9725-4A27-BCAB-E2E1F05F3F21Q34055620-C0877E2B-CDB4-42AE-A4F2-60F9324C6C00Q34195209-70C4AD96-8AD2-46A1-9193-3F8342B2CA47Q34289345-3EC88E1A-E58C-4F11-8424-61DECEC6F355Q34456769-D81CA20E-46E6-4120-8889-8117A9F301FCQ34502663-47D5BFC8-7A6E-4D5B-826E-AAD503392042Q35064355-6FE79A24-F10B-4F02-922C-8A7C41AC6E5BQ35589806-CA0C0765-F9A9-4B09-B605-B30F7BBBAACAQ35611711-F75AFB5A-2815-4A21-8AED-16C26CC854A0Q35785264-44D76989-094D-4BCC-A0BF-99B33143F33CQ36074979-DCA35DB5-569F-4CD5-8B9B-4F4D4BDFC95CQ36138054-186C3327-9F9F-49D5-9328-D08B62E61BF6Q36180686-71222EEF-6D8A-4BD3-A610-726EC0303B84Q36447796-7534A1EA-68B4-4227-981E-AF9FC63BE4A5Q36996171-6930D160-14D2-4421-B9FF-3A4BB55A3429Q37123699-D35F12EA-52DF-42D2-9ADD-31BEBFC8BB90Q37641766-7CDB4BEC-0978-4DC2-82C7-9F1209378380Q38221348-68F2CA61-5E50-4A48-AA6B-0D9AEC2456D6Q38252608-A3639306-F649-4EDE-B7D7-E79D48F64E1BQ38400183-9E643C3C-79A2-400C-8608-53358543E7B4Q38558749-15C00CE6-E609-4E89-B546-97CE1C89964BQ38605374-64D49828-3B7F-473F-ADC9-53D512E43071Q38606216-033A44FD-2D07-47D7-AD19-0E1E90EEC5E5Q38753752-AB425360-557D-48E4-8661-8A813BD7979FQ39000249-247C4D92-CC87-4CB0-8FA3-DD4B3DDA942BQ39034173-B8887E16-0A89-41AD-A573-E99FF42FA79EQ39230029-0270D0F0-7472-4B05-8C0A-B767D759F737Q39384272-7D43133E-435C-426D-8E0A-16BE47B05C54Q40183391-95F8772F-2472-4706-AA6B-95AB85D2072DQ40185624-3B01C02F-EAF4-49DD-937D-8CA211CF0E56Q40287938-F9AED468-FEAB-496A-B6B6-7E481D8D9771Q40510040-49D8ADE8-54A9-47E6-B4E6-FE27D9D252FEQ40651293-39D60F20-5499-4B73-B933-E5FE8A17749CQ41493755-AFFB53DA-00D0-4A75-99B0-FFC567C228D1Q41672748-52DE4AA3-DABA-4AAE-A5BE-FD0A1B303779
P2860
Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Induction of innate lymphoid c ...... n against intestinal infection
@en
Induction of innate lymphoid c ...... against intestinal infection.
@nl
type
label
Induction of innate lymphoid c ...... n against intestinal infection
@en
Induction of innate lymphoid c ...... against intestinal infection.
@nl
prefLabel
Induction of innate lymphoid c ...... n against intestinal infection
@en
Induction of innate lymphoid c ...... against intestinal infection.
@nl
P2093
P2860
P50
P1433
P1476
Induction of innate lymphoid c ...... n against intestinal infection
@en
P2093
P2860
P356
10.1016/J.IMMUNI.2013.10.021
P407
P577
2014-01-09T00:00:00Z